|
|
12121 Wilshire Boulevard Suite 350
Los Angeles, CA 90025 USA
phone:1.310.923.9990
fax:1.310.923.9973
|
|
| Symbol |
XCR |
| Exchange |
AMEX |
| Founded |
0 |
| Employees |
|
|
|
| www.xcorporeal.com
|
|
| Research Sector |
Medical Devices & Tech |
|
 |
| Summary Description |
| Xcorporeal is focused on the commercialization of renal replacement devices. |
|
| Management |
| Kelly J. McCrann, Chief Executive Offficer; Victor Gura, MD,
Chief Medical and Scientific Officer; Robert Weinstein, Chief Financial Officer; James Braig, Senior Vice President of Product Development; Russell T Joseph, Vice President of Disposables Engineering; Barry Fulkerson, Vice President of Hardware Systems; Tae Kim, Vice President of Finance and Accounting
|
| |
|
|
|
|
|
|
|
|
|
|
|
| Description |
|
Xcorporeal is focused on the commercialization of renal replacement devices. These devices remove unwanted chemicals, toxins and excess fluids from the blood, thus replacing many of the essential functions of the damaged kidney. Unlike other renal replacement devices currently on the market, the Xcorporeal devices are user friendly, lightweight, portable and eventually wearable, providing patients with continuous treatments (as opposed to intermittent) and allowing them to achieve a quality of life closer to that of a healthy individual. |
|
|
|
|
|
|
|
|
Biotech & Specialty Pharma
Healthcare Services
Medical Devices & Tech
OneMedPlace Member
AdvaMed Members